MUSCLE AND BACK PAIN RELIEF WITH ASA EXTRA STRENGTH 500 MG — DIN 02243927
ACETYLSALICYLIC ACID : 500 MG METHOCARBAMOL : 400 MG · TECHNILAB PHARMA INC. · TABLET · wholesale supply in Canada
Health Canada status: CANCELLED (UNRETURNED ANNUAL)
What is MUSCLE AND BACK PAIN RELIEF WITH ASA EXTRA STRENGTH?
MUSCLE AND BACK PAIN RELIEF WITH ASA EXTRA STRENGTH 500 MG contains ACETYLSALICYLIC ACID : 500 MG METHOCARBAMOL : 400 MG. It is listed in the Health Canada Drug Product Database under DIN 02243927, held by TECHNILAB PHARMA INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled (unreturned annual), status dated 07-Sep-2017. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Methocarbamol, Combinations Excl Psycholeptics in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
22 holders have a Canadian DIN containing Methocarbamol, Combinations Excl Psycholeptics, across 68 DINs, of which 13 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| VITA HEALTH PRODUCTS INC | 9 | 6 | EXTRA STRENGTH MUSCLE & BACK PAIN ASA 500 MG METHOCARBAMOL 400 MG & ACETYLSALICYLIC ACID 500 MG, EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF, EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF WITH ASA, MUSCLE & BACK PAIN ASA 325 MG METHOCARBAMOL 400 MG & ACETYLSALICYLIC ACID 325 MG, MUSCLE & BACK PAIN RELIEF CAPLETS, +4 more | Sourceable in Canada |
| HALEON CANADA ULC | 4 | 4 | ROBAX PLATINUM, ROBAXACET, ROBAXACET EXTRA STRENGTH, ROBAXISAL EXTRA STRENGTH | Sourceable in Canada |
| MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | 5 | 3 | EXTRA STRENGTH TYLENOL BACK PAIN, EXTRA STRENGTH TYLENOL BODY PAIN NIGHT, MOTRIN PLATINUM MUSCLE & BODY, REGULAR STRENGTH TYLENOL BACK PAIN, REGULAR STRENGTH TYLENOL BODY PAIN NIGHT | Sourceable in Canada |
| TEVA CANADA LIMITED | 9 | 0 | ANALGESIC AND MUSCLE RELAXANT CAPLETS, AXUM, METHOXACET, METHOXACET EXTRA STRENGTH, METHOXISAL EXTRA STRENGTH, +4 more | No marketed DIN |
| PENDOPHARM DIVISION OF PHARMASCIENCE INC | 8 | 0 | MUSCLE & BACK PAIN RELIEF, MUSCLE & BACK PAIN RELIEF EXTRA STRENGTH, MUSCLE AND BACK PAIN RELIEF, MUSCLE AND BACK PAIN RELIEF EXTRA STRENGTH, SUMMIT ULTRA | No marketed DIN |
| CELLCHEM PHARMACEUTICALS INC. | 7 | 0 | A.S.A. WITH METHOCARBAMOL NIGHT-TIME EXTRA STRENGTH, EXTRA STRENGTH BACK PAIN, EXTRA STRENGTH BODY PAIN NIGHT, EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF, MUSCLE AND BACK PAIN RELIEF REGULAR STRENGTH TABLETS, +2 more | No marketed DIN |
| BAYER INC CONSUMER CARE | 3 | 0 | ASPIRIN NIGHT-TIME, EXTRA STRENGTH ASPIRIN BACKACHE, MIDOL NIGHT-TIME | No marketed DIN |
| MARCAN PHARMACEUTICALS INC | 3 | 0 | ACETAMINOPHEN 325MG + METHOCARBAMOL 400MG CAPLETS, ACETAMINOPHEN 500MG + METHOCARBAMOL 400MG EXTRA STRENGTH CAPLETS, IBUPROFEN+METHOCARBAMOL CAPLETS | No marketed DIN |
| TECHNILAB PHARMA INC. | 3 | 0 | MUSCLE AND BACK PAIN RELIEF WITH ASA, MUSCLE AND BACK PAIN RELIEF WITH ASA EXTRA STRENGTH, MUSCLE RELAXANT AND ANALGESIC | No marketed DIN |
| WYETH CONSUMER HEALTHCARE INC. | 3 | 0 | ROBAXACET TABLETS, ROBAXISAL CAPLETS, ROBAXISAL TABLETS | No marketed DIN |
| BAYER INC | 2 | 0 | ASPIRIN BACKACHE, SUPER EXTRA STRENGTH ASPIRIN BACKACHE | No marketed DIN |
| STELLA PHARMACEUTICAL CANADA INC. | 2 | 0 | DODD'S BACK-EASE MUSCLE SPASM AND BACK PAIN RELIEF, DODD'S EXTRA STRENGTH BACK-EASE | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 500 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Methocarbamol, Combinations Excl Psycholeptics |
|---|---|
| ATC code | M03BA53 |
| AHFS class | 12:20.04 ; 28:08.04.24 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02243927 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2243927 |
| Brand name | MUSCLE AND BACK PAIN RELIEF WITH ASA EXTRA STRENGTH |
| Generic / active ingredient | ACETYLSALICYLIC ACID : 500 MG METHOCARBAMOL : 400 MG |
| Market authorization holder | TECHNILAB PHARMA INC. |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | M03BA53 |
| ATC anatomical main group | M — Musculo-skeletal system |
| ATC therapeutic subgroup | M03BA |
| Current status | CANCELLED (UNRETURNED ANNUAL) |
| Status date | 07-Sep-2017 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
13 of 68 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| EXTRA STRENGTH MUSCLE & BACK PAIN ASA 500 MG METHOCARBAMOL 400 MG & ACETYLSALICYLIC ACID 500 MG | 400 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | 02252228 |
| EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF | 500 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | 02239141 |
| EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF WITH ASA | 500 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | 02426625 |
| EXTRA STRENGTH TYLENOL BACK PAIN | 400 MG | TABLET | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | 02290510 |
| EXTRA STRENGTH TYLENOL BODY PAIN NIGHT | 500 MG | TABLET | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | 02357356 |
| MOTRIN PLATINUM MUSCLE & BODY | 200 MG | TABLET | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | 02418967 |
| MUSCLE & BACK PAIN RELIEF CAPLETS | 325 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | 02230790 |
| MUSCLE AND BACK PAIN PLATINUM RELIEF | 200 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | 02422042 |
| MUSCLE AND BACK PAIN RELIEF | 500 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | 02451298 |
| ROBAX PLATINUM | 500 MG | TABLET | HALEON CANADA ULC | MARKETED | 02247147 |
2 · Same class — other molecules in ATC M03BA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Methocarbamol, Combinations Excl Psycholeptics | A.S.A. WITH METHOCARBAMOL NIGHT-TIME EXTRA STRENGTH · ACETAMINOPHEN 325MG + METHOCARBAMOL 400MG CAPLETS · ACETAMINOPHEN 500MG + METHOCARBAMOL 400MG EXTRA STRENGTH CAPLETS · ADVIL BACK PAIN · +54 more | 68 | 13 | Yes |
| Methocarbamol | METHOCARBAMOL INJ 100MG/ML · METHOCARBAMOL OMEGA · PMS-METHOCARBAMOL INJ 100MG/ML · ROBAXIMOL INJ 100MG/ML · +4 more | 8 | 1 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC M03B
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| M03BX | Baclofen · Cyclobenzaprine · Tizanidine | 87 | 35 |
| M03BC | Orphenadrine (Citrate) · Orphenadrine, Combinations | 7 | 1 |
| M03BB | Chlorzoxazone, Combinations Excl Psycholeptics | 8 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled (unreturned annual) in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.